The global COVID-19 pandemic negatively impacted the Japanese heart valve device market to some extent. However, in the longer term, the market will be driven by positive results from THV device clinical trials, new product launches, and the rapid adoption of THV devices, resulting in moderate growth through 2031.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for heart valve devices in Japan from 2019 through 2031.
The COVID-19 pandemic is having a significant impact on cardiovascular medtech markets.
How have heart valve procedure volumes been recovering since the initial impact of the COVID-19 pandemic?
Has there been any impact from subsequent COVID-19 waves on procedure volumes?
Transcatheter replacement therapies will be the driving the replacement device market in Japan.
Which new TAVR devices are poised to enter the market? What impact will these newer devices have on market dynamics and market growth?
What new transcatheter replacement devices have been approved in the Japanese market? How will they impact the overall heart valve device market?
When is TMVI therapy expected to enter the Japanese market? What TMVI devices are in development?
What types of patients will be eligible for TAVR? How will the approval of expanded indications for TAVR impact the market?
How will MHLW reimbursement affect TAVR adoption?
The approval of Abbott Laboratories’ MitraClip introduced TMVR to the Japanese market for the first time.
How will the competitive landscape change once new TMVR devices are launched in the market?
How will the TTVR market grow over the forecast period?
MHLW reimbursement revisions will affect the Japanese heart valve device market.
How has the regulatory framework in Japan changed to streamline to global regulatory requirements?
What is the impact of Japan’s regulatory approval process on product launches in Japan?
What other factors will affect ASP trends?
There are a few large, entrenched competitors in the Japanese heart valve device market.
What hurdles exist for new competitors trying to enter the Japanese heart valve device market, and what strategies can they use to overcome these barriers?
How will physician perception result in adoption of devices in Japan? Will it have any impact on brand preference?
- Heart Valve Devices - Market Insights - Japan
- COVID-19 Methodology
- Abstract
- Executive Summary
- Key Report Updates
- COVID-19 Analysis
- Heart Valve Device Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Heart Valve Device Procedures, by Procedure Type, Japan, 2019u20132031
- Heart Valve Device Procedures, by Position, Japan, 2019u20132031
- Aortic Heart Valve Device Procedures, by Product Type, Japan, 2019u20132031
- Mitral Heart Valve Device Procedures, by Procedure Type, Japan, 2019u20132031
- Mitral Heart Valve Device Procedures, by Product Type, Japan, 2019u20132031
- Other Position Heart Valve Device Procedures, by Procedure Type, Japan, 2019u20132031
- Other Position Heart Valve Device Procedures, by Product Type, Japan, 2019u20132031
- Heart Valve Device Market, by Procedure Type, Japan (USD), 2019u20132031
- Heart Valve Device Market, by Product Type, Japan (USD), 2019u20132031
- Heart Valve Device Market Growth, by Product Type, Japan, 2020u20132031
- Market Shares
- Competitive Insights
- Market Developments
- Heart Valve Replacement Device Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Heart Valve Replacement Device Procedures, by Position, Japan, 2019u20132031
- Heart Valve Replacement Device Procedures, by Technique, Japan, 2019u20132031
- Heart Valve Replacement Device Procedures, by Product Type, Japan, 2019u20132031
- Aortic Heart Valve Replacement Device Procedures, by Technique, Japan, 2019u20132031
- Aortic Heart Valve Replacement Device Procedures, by Product Type, Japan, 2019u20132031
- Mitral Heart Valve Replacement Device Procedures, by Technique, Japan, 2019u20132031
- Mitral Heart Valve Replacement Device Procedures, by Product Type, Japan, 2019u20132031
- Other Heart Valve Replacement Device Procedures, by Product Type, Japan, 2019u20132031
- Heart Valve Replacement Device Market, by Product Type, Japan (USD), 2019u20132031
- Heart Valve Replacement Device Market Growth, by Product Type, Japan, 2020u20132031
- Surgical Heart Valve Replacement Devices
- Transcatheter Heart Valve Replacement Devices
- Market Shares
- Competitive Insights
- Heart Valve Repair Device Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Heart Valve Repair Device Procedures, by Position, Japan, 2019u20132031
- Heart Valve Repair Device Procedures, by Technique, Japan, 2019u20132031
- Mitral Heart Valve Repair Device Procedures, by Technique, Japan, 2019u20132031
- Tricuspid Heart Valve Repair Device Procedures, by Technique, Japan, 2019u20132031
- Heart Valve Repair Device Market, by Technique, Japan (USD), 2019u20132031
- Heart Valve Repair Device Market Growth, by Technique, Japan, 2020u20132031
- Transcatheter Heart Valve Repair Devices
- Market Shares
- Competitive Insights
- Heart Valve Accessory Device Market
- Appendix
Anusha Naik
Anusha Naik is a member of the Cardiovascular Medtech Insights team at Clarivate, specializing in the heart valve device market. Anusha holds a Bachelor’s degree in Pharmaceutical Sciences from Goa College of Pharmacy, Goa and a Master’s degree in Pharmaceutical Quality Assurance from the Manipal Academy of Higher Education, Manipal.